Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR Trial.
Ophthalmology
View this publicationOphthalmology
View this publicationJCI insight
View this publicationCardiovascular research
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationOncoimmunology
View this publicationBiomedicines
View this publicationPatient education and counseling
View this publicationAlzheimer's research & therapy
View this publicationTH open : companion journal to thrombosis and haemostasis
View this publicationNature communications
View this publication